Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegileridine vs morphine for perioperative neurocognitive outcomes in elderly gastrointestinal cancer surgery
ChiCTR2500114396Phase 4Not yet recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tegileridine in perioperative neurocognitive disorder, postoperative delirium (POD), cognitive disorder (CD) and 1 more (2 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoint: Incidence of postoperative delirium (POD). Planned start Dec 2025; status: not yet recruiting.
02
Drugs
tegileridine
03
Conditions
perioperative neurocognitive disorderpostoperative delirium (POD)cognitive disorder (CD)postoperative pain
Beyond the preview
Go deeper on ChiCTR2500114396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500114396.